Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Dik, Jan Willem H ^a   Hendrix, Ron ^a,b   Friedrich, Alex W ^a   Luttjeboer, Jos ^c   Panday, Prashant Nannan ^a   Wilting, Kasper R ^a   Lo Ten Foe, Jerome R ^a   Postma, Maarten J ^a,c   Sinha, Bhanu ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Medical Microbiology   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; COHORT ANALYSIS; COMMERCIAL PHENOMENA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST MINIMIZATION ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MIDDLE AGED; MULTIDISCIPLINARY ANTIMICROBIAL STEWARDSHIP PROGRAM; PROGRAM COST EFFECTIVENESS; RETURN ON INVESTMENT; TEAMWORK; UNIVERSITY HOSPITAL; UROLOGY WARD; WARD; DIAGNOSIS RELATED GROUP; ECONOMIC MODEL; ECONOMICS; HOSPITAL DEPARTMENT; HOSPITALIZATION; NETHERLANDS; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; DIAGNOSIS-RELATED GROUPS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; MODELS, ECONOMIC; NETHERLANDS; REFERRAL AND CONSULTATION; UROLOGY DEPARTMENT, HOSPITAL;

EID: 84937017487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126106     Document Type: Article

References (36)

1. Nowak MN, Breidenbach R, Thompson J, Carson P. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm. 2012;69:1500-1508. doi: 10.2146/ajhp110603 PMID: 22899745
2. Cosgrove S. The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42 Suppl 2:S82-S89. PMID: 16355321
3. Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: Implications for antibiotic stewardship. Clin Infect Dis. 2009;49:1175-1184. doi: 10.1086/605630 PMID: 19739972
4. de Kraker ME, Davey PG, Grundmann H, BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: Estimating the burden of antibiotic resistance in Europe. PLoS Medicine. 2011;8:e1001104. doi: 10.1371/journal.pmed.1001104 PMID: 22022233
5. ECDC/EMEA Joint Working Group. The bacterial challenge: Time to react. EMEA/576176 2009;13-42.
6. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493. doi: 10.1136/bmj. f1493 PMID: 23479660
7. World Health Organization. The evolving threat of antimicrobial resistance-options for action. 2012. Available: http://whqlibdoc.who.int/publications/2012/9789241503181 eng.pdf. Accessed 25 July 2014
8. Morgan D, Astolfi R. Health spending continues to stagnate in many OECD countries. OECD Health Working Papers. 2014;68:25.
9. World Health Organization. Health systems in times of global economic crisis: An update of the situation in the WHO-European region. 2014;1:27-37. Available: http://www.euro.who.int/data/assets/pdf file/0007/190456/HEALTH-SYSTEMS-IN-TIMES-OF-GLOBAL-ECONOMIC-CRISIS-AN-UPDATE-OF-THE-SITUATION-IN-THE-WHO,-Oslo,-Norway,-1718-April-2013-Eng.pdf. Accessed 4 July 2014
10. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, etal. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543. doi: 10.1002/14651858. CD003543.pub3 PMID: 23633313
11. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein R, Burke JP, etal. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177. PMID: 17173212
12. With de K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, etal. S3-leitlinie. Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. 2013. Available: http://www.awmf.org/uploads/tx szleitlinien/092-001l S3 Antibiotika Anwendung im Krankenhaus 2013-12.pdf. Accessed4 July 2014.
13. Dik JH, Vemer P, Friedrich AW, Hendrix R, Lo-Ten-Foe JR, Sinha B, etal. Financial evaluations of antibiotic stewardship programs-a systematic review. Front Microbiol. 2015 Mar. 30. doi: 10.3389/fmicb. 2015.00317
14. Goff DA, Bauer KA, Reed EE, Stevenson KB, Taylor JJ, West JE. Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs? Clin Infect Dis. 2012;55:587-592. doi: 10.1093/cid/cis494 PMID: 22615329
15. Gray A, Dryden M, Charos A. Antibiotic management and early discharge from hospital: An economic analysis. J Antimicrob Chemother. 2012;67:2297-2302. doi: 10.1093/jac/dks194 PMID: 22623630
16. Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: A probabilistic analysis. J Antimicrob Chemother. 2009;63:816-825. doi: 10.1093/jac/dkp004 PMID: 19202150
17. Lo-Ten-Foe JR, Sinha B, Wilting KR, Veenstra-Kyuchukova Y, Panday PN, Hendrix R. [Bedside consultation by a multidisciplinary antibiotics team: An antibiotic stewardship programme at UMCG]. Ned TijdschrGeneeskd. 2014;158:A6795. PMID: 24472339
18. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. [Guidelines for pharmacoeconomic research, methods and standard cost prices for economic evaluations in health care]. 2010. Available: https://www.zorginstituutnederland.nl/binaries/content/documents/zinl-www/documenten/publicaties/overigepublicaties/1007-handleiding-voor-kostenonderzoek/Handleiding+voor+kostenonderzoek.pdf. Accessed2 July 2014.
19. Niwa T, Shinoda Y, Suzuki A, Ohmori T, Yasuda M, Yasuda M, etal. Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital. Int J Clin Pract. 2012;66:999-1008. doi: 10.1111/j.1742-1241.2012.02999.x PMID: 22846073
20. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013;137:1247-1254. doi: 10.5858/arpa.2012-0651-OA PMID: 23216247
21. Hamblin S, Rumbaugh K, Miller R. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic level I trauma center: An evidence-based approach. J Trauma Acute Care Surg. 2012;73:1484-1490. doi: 10.1097/TA.0b013e318267cd80 PMID: 23064610
22. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Diseases. 2001;33:289-295. PMID: 11438891
23. Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, Ramsay C, etal. Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis. J Antimicrob Chemother. 2003;52:842-848. PMID: 14563900
24. Rüttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348-356. PMID: 14727204
25. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Cost analysis. In: Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 2005. pp. 55-101. PMID: 15693028
26. Handoko KB, van Asselt GJ, Overdiek JW. [Preventing prolonged antibiotic therapy by active implementation of switch guidelines]. Ned TijdschrGeneeskd. 2004;148:222-226. PMID: 14983578
27. Tice AD, Turpin RS, Hoey CT, Lipsky B, Wu J, Abramson MA. Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections. Am J Health Syst Pharm. 2007;64:1080-1086. PMID: 17494908
28. van Zanten ARH, Engelfriet P, van Dillen K, van Veen M, Nuijten MJC, Polderman KH. Importance of nondrug costs of intravenous antibiotic therapy. CritCare. 2003;7:R184-R190. PMID: 14624694
29. Aiken LH, Clarke S, Sloane DM. Hospital staffing, organization, and quality of care: Cross-national findings. Nurs Outlook. 2002;50:187-194. PMID: 12386653
30. Clements A, Halton K, Graves N, Pettitt A, Morton A, Looke D, et al. Overcrowding and understaffing in modern health-care systems: Key determinants in meticillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis. 2008;8:427-434. doi: 10.1016/S1473-3099 (08) 70151-8 PMID: 18582835
31. De Angelis G, Murthy A, Beyersmann J, Harbarth S. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin Microbiol Infect. 2010;16:1729-1735. doi: 10.1111/j.1469-0691.2010.03332.x PMID: 20673257
32. Jönsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10:357-359. doi: 10.1007/s10198-009-0173-2 PMID: 19618224
33. Ciccolini M, Donker T, Köck R, Mielke M, Hendrix R, Jurke A, etal. Infection prevention in a connected world: The case for a regional approach. Int J Med Microbiol. 2013;306:380-387.
34. van Cleef BAGL, Kluytmans JAJW, van Benthem BHB, Haenen A, Monen J, Daniels-Haardt I, etal. Cross border comparison of MRSA bacteraemia between the Netherlands and North Rhine-Westphalia (Germany): A cross-sectional study. PLoSONE. 2012;7:e42787. doi: 10.1371/journal.pone.0042787 PMID: 22880109
35. Donker T, Wallinga J, Slack R, Grundmann H. Hospital networks and the dispersal of hospital-acquired pathogens by patient transfer. PLoSONE. 2012;7:e35002. doi: 10.1371/journal.pone.0035002 PMID: 22558106
36. Rudholm N. Economic implications of antibiotic resistance in a global economy. J Health Econ. 2002;21:1071-1083. PMID: 12475126